Bridge Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,662
| Closed | -$448K | – | 127 |
|
|
2023
Q3 | $448K | Buy |
3,662
+1,283
| +54% | +$157K | 0.16% | 95 |
|
|
2023
Q2 | $302K | Sell |
2,379
-111
| -4% | -$14.1K | 0.11% | 103 |
|
|
2023
Q1 | $322K | Sell |
2,490
-46
| -2% | -$5.94K | 0.12% | 95 |
|
|
2022
Q4 | $333K | Sell |
2,536
-92
| -4% | -$12.1K | 0.14% | 101 |
|
|
2022
Q3 | $307K | Sell |
2,628
-224
| -8% | -$26.2K | 0.15% | 89 |
|
|
2022
Q2 | $352K | Sell |
2,852
-59
| -2% | -$7.28K | 0.17% | 82 |
|
|
2022
Q1 | $379K | Sell |
2,911
-635
| -18% | -$82.7K | 0.17% | 73 |
|
|
2021
Q4 | $541K | Buy |
3,546
+235
| +7% | +$35.9K | 0.24% | 62 |
|
|
2021
Q3 | $535K | Buy |
3,311
+276
| +9% | +$44.6K | 0.26% | 53 |
|
|
2021
Q2 | $497K | Buy |
3,035
+1
| +0% | +$164 | 0.25% | 53 |
|
|
2021
Q1 | $457K | Buy |
3,034
+1
| +0% | +$151 | 0.28% | 40 |
|
|
2020
Q4 | $459K | Buy |
+3,033
| New | +$459K | 0.22% | 56 |
|